PHR:NYE-Phreesia Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 25.4

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.56M

Analyst Target

USD 30.11
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-17 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
DOCS Doximity Inc

N/A

USD 11.11B
WEAV Weave Communications Inc

N/A

USD 0.71B
AMWL American Well Corp

N/A

USD 0.11B
CTEV Claritev Corporation

N/A

N/A
EVH Evolent Health Inc

N/A

N/A
TDOC Teladoc Inc

N/A

N/A
VEEV Veeva Systems Inc Class A

N/A

N/A
FOXO FOXO Technologies Inc.

N/A

N/A

ETFs Containing PHR

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.95% 63% D 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.95% 63% D 53% F
Trailing 12 Months  
Capital Gain 4.48% 50% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.48% 50% F 49% F
Trailing 5 Years  
Capital Gain -8.30% 50% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.30% 50% F 14% F
Average Annual (5 Year Horizon)  
Capital Gain -0.13% 63% D 34% F
Dividend Return -0.13% 63% D 22% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 53.39% 75% C 15% F
Risk Adjusted Return -0.25% 63% D 23% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector